Your Shopping Cart Is Empty
| ✷ Report Code: A03399 | Feb 2022 | Pages: 270 | ||
| Tables: 134 | Charts: 59 |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Interbody Fusion Cage Market
Request Now !The global Interbody Fusion Cage Market size was valued at $ 1901.67 million in 2020, and is projected to reach $3012.47 million by 2030, registering a CAGR of 4.7% from 2021 to 2030. Interbody fusion cage is an artificial medical device, which is utilized in spinal fusion procedures to maintain foraminal height and decompression. The interbody fusion cage is a large, hollow cylinder made up of metals such as titanium, carbon fiber, or allograft femur. The device is designed as a cage so that bone graft can be placed inside the hollow cylinder to allow a spinal fusion to occur between two vertebrae. Interbody fusion cage is utilized to provide stability to the spine and the cervical region. The cages can be filled with autologous bone material to promote arthrodesis (artificial induction of joint ossification).
The global interbody fusion cages is expected to exhibit significant growth during the forecast period, owing to increase in demand for interbody fusion cage surgeries due to advantages that allow the surgeon to directly decompress nerves and reconstruct the spine. In addition, the key factors driving the market growth are increase in geriatric population and rise in cases of spinal cord injuries, which might be caused due to accidents and diseases such as degenerative disk disease. Moreover, upsurge in disposable income in the developing economies such as India and China contribute toward the growth of the market. However, high cost associated with spinal fusion surgeries, lack of skilled professionals, and increase in disposable incomes in emerging economies restrain the Interbody fusion cages market growth.
The global interbody fusion cages market is segmented into product type, surgery, end user, and region. On the basis of product type, the market is fragmented into lumbar, cervical, thoraco-lumbar, and thoracic. By surgery, it is categorized into anterior, posterior, lateral, and transforaminal. Depending on end user, it is segregated into hospitals & clinics, ambulatory surgical centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Coronavirus (COVID-19) was discovered in December 2019 in Hubei province of Wuhan city in China. The disease is caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is transmitted among humans.
After its discovery in Wuhan, the disease rapidly spread to other parts of the globe. Moreover, this virus causes various symptoms in patients, which range from common symptoms to serious symptoms. For instance, common symptoms include fever, dry cough, and fatigue. However, serious symptoms include difficulty in breathing or shortness of breath, chest pain or pressure, and loss of speech or movement. Furthermore, the virus has high potential of lethality in geriatric population. On March 11, 2020, the World Health Organization made an assessment that COVID-19 can be characterized as pandemic. In addition, only a few vaccines that received emergency approvals for COVID-19 prevention. Thus, social distancing is observed as the most important measure to stop the spread of this disease.
The outbreak of COVID-19 has disrupted workflows in the healthcare sector around the world. The disease has forced a number of industries to shut their doors temporarily, including several subdomains of healthcare. Moreover, there has been a negative effect on various services, including interbody fusion cage industry. For instance, according to the Commonwealth Fund, it was estimated that there was a nearly 60% initial decrease in overall outpatient visits by May 2020 due to COVID-19. This was expected to negatively affect the demand for interbody fusion cage for spinal fusion as they are usually conducted in outpatient departments. In addition, according to article published in Europe PMC, the pandemic has affected outpatient clinics, emergency and elective surgery, rehabilitation, resident training, personnel management, use of personal protective equipment, telemedicine, and all sub-specialties of orthopedics that conduct spinal procedures.
The outbreak of COVID-19 impacted the Interbody fusion cage market, as hospital and healthcare services were significantly reduced due to social distancing measures taken by governments across the world. Moreover, the COVID-19 pandemic affected the global economy and showed a huge impact on the functioning of general hospital care for non-COVID-19 patients in hospitals across the globe. As many hospitals and clinics remain closed due to lockdown, the demand for interbody fusion cage procedures is expected to be subdued in the short term. For instance, according to a study published in the British Journal of Surgery, in May 2020, based on 12 weeks of peak disruption to hospital services due to COVID-19, around 28.4 million elective surgeries worldwide were canceled or postponed in 2020.
By product type, the lumbar cage segment was the major revenue contributor in 2020, and is anticipated to continue this trend during the forecast period, owing to increase in cervical fusion surgeries, as they preserve the motion of the spine, do not need bone grafting & cervical disc replacement, and do not require a plate be placed directly in the front of the spine. On the other side, the thoracic cage segment is projected to exhibit the fastest market growth during the forecast period, owing to rise in use of thoracic cage.
By application, the anterior segment presently dominates the Interbody fusion cages market, and is expected to remain dominant during the forecast period, owing to ease in accessing the body from the front section.
By end user, the hospitals segment presently dominates the Interbody fusion cages market, and is expected to remain dominant during the forecast period, owing to increase number of spinal fusion performed at hospitals. Growing government initiatives to improve the healthcare infrastructure and expanding the middle-class population in developing nations such as India are resulting in increasing demand for quality healthcare services delivered by hospitals, thereby aiding segment growth.
Region wise, North America dominated the market in 2020, accounting for the highest share, and is anticipated to maintain this trend throughout the forecast period. Owing to the increase in incidence of spinal impairments in the U.S. Furthermore, rise in aging population and increase in product launches in the region are expected to drive the Interbody fusion cages market growth.
This report provides comprehensive competitive analysis and profiles of prominent market players of Interbody fusion cages market such as Aurora Spine, Inc., B. Braun Melsungen AG, Benvenue Medical Inc., Prodorth, Ulrich Medicals, Orthofix, Medtronic Plc, Zimmer Biomet Holdings, Inc., NuVasive, Inc., and Johnson & Johnson.
Key benefits for stakeholders
Interbody Fusion Cage Market Report Highlights
| Aspects | Details |
|---|---|
| By Product Type |
|
| By Surgery |
|
| By End users |
|
| By Region |
|
| By KEY PLAYERS |
|
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1.CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1.Market Definition and Scope
3.2.Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3.Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Share Analysis/Top Player Positioning
3.4.1. Market Share Analysis/Top Player Positioning 2020
3.5. Market Dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis
CHAPTER 4: INTERBODY FUSION CAGES MARKET, BY PRODUCT
4.1. Market Overview
4.1.1Market Size and Forecast, By Product
4.2. Lumbar
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Cervical
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Thoraco Lumbar
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
4.5. Thoracic
4.5.1. Key Market Trends, Growth Factors and Opportunities
4.5.2. Market Size and Forecast, By Region
4.5.3. Market Share Analysis, By Country
CHAPTER 5: INTERBODY FUSION CAGES MARKET, BY SURGERY
5.1. Market Overview
5.1.1Market Size and Forecast, By Surgery
5.2. Anterior
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Transforaminal
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Posterior
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
5.5. Lateral
5.5.1. Key Market Trends, Growth Factors and Opportunities
5.5.2. Market Size and Forecast, By Region
5.5.3. Market Share Analysis, By Country
CHAPTER 6: INTERBODY FUSION CAGES MARKET, BY END USER
6.1. Market Overview
6.1.1Market Size and Forecast, By End User
6.2. Hospitals And Clinics
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Ambulatory Surgical Centers
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Others
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
CHAPTER 7: INTERBODY FUSION CAGES MARKET, BY REGION
7.1. Market Overview
7.1.1Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Product
7.2.3. Market Size and Forecast, By Surgery
7.2.4. Market Size and Forecast, By End User
7.2.5. Market Size and Forecast, By Country
7.2.6. U.s. Interbody Fusion CAGES Market
7.2.6.1. Market Size and Forecast, By Product
7.2.6.2. Market Size and Forecast, By Surgery
7.2.6.3. Market Size and Forecast, By End User
7.2.7. Canada Interbody Fusion CAGES Market
7.2.7.1. Market Size and Forecast, By Product
7.2.7.2. Market Size and Forecast, By Surgery
7.2.7.3. Market Size and Forecast, By End User
7.2.8. Mexico Interbody Fusion CAGES Market
7.2.8.1. Market Size and Forecast, By Product
7.2.8.2. Market Size and Forecast, By Surgery
7.2.8.3. Market Size and Forecast, By End User
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Product
7.3.3. Market Size and Forecast, By Surgery
7.3.4. Market Size and Forecast, By End User
7.3.5. Market Size and Forecast, By Country
7.3.6. Germany Interbody Fusion CAGES Market
7.3.6.1. Market Size and Forecast, By Product
7.3.6.2. Market Size and Forecast, By Surgery
7.3.6.3. Market Size and Forecast, By End User
7.3.7. France Interbody Fusion CAGES Market
7.3.7.1. Market Size and Forecast, By Product
7.3.7.2. Market Size and Forecast, By Surgery
7.3.7.3. Market Size and Forecast, By End User
7.3.8. Uk Interbody Fusion CAGES Market
7.3.8.1. Market Size and Forecast, By Product
7.3.8.2. Market Size and Forecast, By Surgery
7.3.8.3. Market Size and Forecast, By End User
7.3.9. Italy Interbody Fusion CAGES Market
7.3.9.1. Market Size and Forecast, By Product
7.3.9.2. Market Size and Forecast, By Surgery
7.3.9.3. Market Size and Forecast, By End User
7.3.10. Spain Interbody Fusion CAGES Market
7.3.10.1. Market Size and Forecast, By Product
7.3.10.2. Market Size and Forecast, By Surgery
7.3.10.3. Market Size and Forecast, By End User
7.3.11. Rest Of Europe Interbody Fusion CAGES Market
7.3.11.1. Market Size and Forecast, By Product
7.3.11.2. Market Size and Forecast, By Surgery
7.3.11.3. Market Size and Forecast, By End User
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Product
7.4.3. Market Size and Forecast, By Surgery
7.4.4. Market Size and Forecast, By End User
7.4.5. Market Size and Forecast, By Country
7.4.6. Japan Interbody Fusion CAGES Market
7.4.6.1. Market Size and Forecast, By Product
7.4.6.2. Market Size and Forecast, By Surgery
7.4.6.3. Market Size and Forecast, By End User
7.4.7. China Interbody Fusion CAGES Market
7.4.7.1. Market Size and Forecast, By Product
7.4.7.2. Market Size and Forecast, By Surgery
7.4.7.3. Market Size and Forecast, By End User
7.4.8. Australia Interbody Fusion CAGES Market
7.4.8.1. Market Size and Forecast, By Product
7.4.8.2. Market Size and Forecast, By Surgery
7.4.8.3. Market Size and Forecast, By End User
7.4.9. India Interbody Fusion CAGES Market
7.4.9.1. Market Size and Forecast, By Product
7.4.9.2. Market Size and Forecast, By Surgery
7.4.9.3. Market Size and Forecast, By End User
7.4.10. South Korea Interbody Fusion CAGES Market
7.4.10.1. Market Size and Forecast, By Product
7.4.10.2. Market Size and Forecast, By Surgery
7.4.10.3. Market Size and Forecast, By End User
7.4.11. Rest of Asia Pacific Interbody Fusion CAGES Market
7.4.11.1. Market Size and Forecast, By Product
7.4.11.2. Market Size and Forecast, By Surgery
7.4.11.3. Market Size and Forecast, By End User
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Product
7.5.3. Market Size and Forecast, By Surgery
7.5.4. Market Size and Forecast, By End User
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Interbody Fusion CAGES Market
7.5.6.1. Market Size and Forecast, By Product
7.5.6.2. Market Size and Forecast, By Surgery
7.5.6.3. Market Size and Forecast, By End User
7.5.7. South Africa, Interbody Fusion CAGES Market
7.5.7.1. Market Size and Forecast, By Product
7.5.7.2. Market Size and Forecast, By Surgery
7.5.7.3. Market Size and Forecast, By End User
7.5.8. Saudi Arabia Interbody Fusion CAGES Market
7.5.8.1. Market Size and Forecast, By Product
7.5.8.2. Market Size and Forecast, By Surgery
7.5.8.3. Market Size and Forecast, By End User
7.5.9. Rest of LAMEA Interbody Fusion CAGES Market
7.5.9.1. Market Size and Forecast, By Product
7.5.9.2. Market Size and Forecast, By Surgery
7.5.9.3. Market Size and Forecast, By End User
CHAPTER 8: COMPANY PROFILES
8.1. Atom Medical Corporation
8.1.1. Company Overview
8.1.2. Key Executives
8.1.3. Company snapshot
8.1.4. Operating business segments
8.1.5. Product portfolio
8.1.6. Business Performance
8.1.7. Key Strategic Moves and Developments
8.2. AVI Healthcare Pvt. Ltd
8.2.1. Company Overview
8.2.2. Key Executives
8.2.3. Company snapshot
8.2.4. Operating business segments
8.2.5. Product portfolio
8.2.6. Business Performance
8.2.7. Key Strategic Moves and Developments
8.3. Equalize Heath, Inc
8.3.1. Company Overview
8.3.2. Key Executives
8.3.3. Company snapshot
8.3.4. Operating business segments
8.3.5. Product portfolio
8.3.6. Business Performance
8.3.7. Key Strategic Moves and Developments
8.4. GE Healthcare
8.4.1. Company Overview
8.4.2. Key Executives
8.4.3. Company snapshot
8.4.4. Operating business segments
8.4.5. Product portfolio
8.4.6. Business Performance
8.4.7. Key Strategic Moves and Developments
8.5. Ibis Medical Equipment And Systems Pvt. Ltd
8.5.1. Company Overview
8.5.2. Key Executives
8.5.3. Company snapshot
8.5.4. Operating business segments
8.5.5. Product portfolio
8.5.6. Business Performance
8.5.7. Key Strategic Moves and Developments
8.6. Natus Medical Incorporated
8.6.1. Company Overview
8.6.2. Key Executives
8.6.3. Company snapshot
8.6.4. Operating business segments
8.6.5. Product portfolio
8.6.6. Business Performance
8.6.7. Key Strategic Moves and Developments
8.7. Ningbo David Medical Device Co. Ltd
8.7.1. Company Overview
8.7.2. Key Executives
8.7.3. Company snapshot
8.7.4. Operating business segments
8.7.5. Product portfolio
8.7.6. Business Performance
8.7.7. Key Strategic Moves and Developments
8.8. Novos Medical Devices San. Tic. Imp. And Ihr. Ltd. Sti.
8.8.1. Company Overview
8.8.2. Key Executives
8.8.3. Company snapshot
8.8.4. Operating business segments
8.8.5. Product portfolio
8.8.6. Business Performance
8.8.7. Key Strategic Moves and Developments
8.9. Weyer GmbH
8.9.1. Company Overview
8.9.2. Key Executives
8.9.3. Company snapshot
8.9.4. Operating business segments
8.9.5. Product portfolio
8.9.6. Business Performance
8.9.7. Key Strategic Moves and Developments
8.10. Zhengzhou Dison Instrument And Meter Co. Ltd
8.10.1. Company Overview
8.10.2. Key Executives
8.10.3. Company snapshot
8.10.4. Operating business segments
8.10.5. Product portfolio
8.10.6. Business Performance
8.10.7. Key Strategic Moves and Developments
LIST OF TABLES
TABLE 1.GLOBAL INTERBODY FUSION CAGES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 2.GLOBAL INTERBODY FUSION CAGES MARKET FOR LUMBAR, BY REGION, 2020-2030 ($MILLION)
TABLE 3.GLOBAL INTERBODY FUSION CAGES MARKET FOR CERVICAL, BY REGION, 2020-2030 ($MILLION)
TABLE 4.GLOBAL INTERBODY FUSION CAGES MARKET FOR THORACO LUMBAR, BY REGION, 2020-2030 ($MILLION)
TABLE 5.GLOBAL INTERBODY FUSION CAGES MARKET FOR THORACIC, BY REGION, 2020-2030 ($MILLION)
TABLE 6.GLOBAL INTERBODY FUSION CAGES MARKET, BY SURGERY, 2020-2030 ($MILLION)
TABLE 7.GLOBAL INTERBODY FUSION CAGES MARKET FOR ANTERIOR, BY REGION, 2020-2030 ($MILLION)
TABLE 8.GLOBAL INTERBODY FUSION CAGES MARKET FOR TRANSFORAMINAL, BY REGION, 2020-2030 ($MILLION)
TABLE 9.GLOBAL INTERBODY FUSION CAGES MARKET FOR POSTERIOR, BY REGION, 2020-2030 ($MILLION)
TABLE 10.GLOBAL INTERBODY FUSION CAGES MARKET FOR LATERAL, BY REGION, 2020-2030 ($MILLION)
TABLE 11.GLOBAL INTERBODY FUSION CAGES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 12.GLOBAL INTERBODY FUSION CAGES MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2020-2030 ($MILLION)
TABLE 13.GLOBAL INTERBODY FUSION CAGES MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2020-2030 ($MILLION)
TABLE 14.GLOBAL INTERBODY FUSION CAGES MARKET FOR OTHERS, BY REGION, 2020-2030 ($MILLION)
TABLE 15.GLOBAL INTERBODY FUSION CAGES MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 16.NORTH AMERICA INTERBODY FUSION CAGES, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 17.NORTH AMERICA INTERBODY FUSION CAGES, BY SURGERY, 2020-2030 ($MILLION)
TABLE 18.NORTH AMERICA INTERBODY FUSION CAGES, BY END USER, 2020-2030 ($MILLION)
TABLE 19.U.S. INTERBODY FUSION CAGES, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 20.U.S. INTERBODY FUSION CAGES, BY SURGERY, 2020-2030 ($MILLION)
TABLE 21.U.S. INTERBODY FUSION CAGES, BY END USER, 2020-2030 ($MILLION)
TABLE 22.CANADA INTERBODY FUSION CAGES, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 23.CANADA INTERBODY FUSION CAGES, BY SURGERY, 2020-2030 ($MILLION)
TABLE 24.CANADA INTERBODY FUSION CAGES, BY END USER, 2020-2030 ($MILLION)
TABLE 25.MEXICO INTERBODY FUSION CAGES, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 26.MEXICO INTERBODY FUSION CAGES, BY SURGERY, 2020-2030 ($MILLION)
TABLE 27.MEXICO INTERBODY FUSION CAGES, BY END USER, 2020-2030 ($MILLION)
TABLE 28.EUROPE INTERBODY FUSION CAGES, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 29.EUROPE INTERBODY FUSION CAGES, BY SURGERY, 2020-2030 ($MILLION)
TABLE 30.EUROPE INTERBODY FUSION CAGES, BY END USER, 2020-2030 ($MILLION)
TABLE 31.GERMANY INTERBODY FUSION CAGES, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 32.GERMANY INTERBODY FUSION CAGES, BY SURGERY, 2020-2030 ($MILLION)
TABLE 33.GERMANY INTERBODY FUSION CAGES, BY END USER, 2020-2030 ($MILLION)
TABLE 34.FRANCE INTERBODY FUSION CAGES, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 35.FRANCE INTERBODY FUSION CAGES, BY SURGERY, 2020-2030 ($MILLION)
TABLE 36.FRANCE INTERBODY FUSION CAGES, BY END USER, 2020-2030 ($MILLION)
TABLE 37.UK INTERBODY FUSION CAGES, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 38.UK INTERBODY FUSION CAGES, BY SURGERY, 2020-2030 ($MILLION)
TABLE 39.UK INTERBODY FUSION CAGES, BY END USER, 2020-2030 ($MILLION)
TABLE 40.ITALY INTERBODY FUSION CAGES, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 41.ITALY INTERBODY FUSION CAGES, BY SURGERY, 2020-2030 ($MILLION)
TABLE 42.ITALY INTERBODY FUSION CAGES, BY END USER, 2020-2030 ($MILLION)
TABLE 43.SPAIN INTERBODY FUSION CAGES, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 44.SPAIN INTERBODY FUSION CAGES, BY SURGERY, 2020-2030 ($MILLION)
TABLE 45.SPAIN INTERBODY FUSION CAGES, BY END USER, 2020-2030 ($MILLION)
TABLE 46.REST OF EUROPE INTERBODY FUSION CAGES, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 47.REST OF EUROPE INTERBODY FUSION CAGES, BY SURGERY, 2020-2030 ($MILLION)
TABLE 48.REST OF EUROPE INTERBODY FUSION CAGES, BY END USER, 2020-2030 ($MILLION)
TABLE 49.ASIA-PACIFIC INTERBODY FUSION CAGES, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 50.ASIA-PACIFIC INTERBODY FUSION CAGES, BY SURGERY, 2020-2030 ($MILLION)
TABLE 51.ASIA-PACIFIC INTERBODY FUSION CAGES, BY END USER, 2020-2030 ($MILLION)
TABLE 52.JAPAN INTERBODY FUSION CAGES, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 53.JAPAN INTERBODY FUSION CAGES, BY SURGERY, 2020-2030 ($MILLION)
TABLE 54.JAPAN INTERBODY FUSION CAGES, BY END USER, 2020-2030 ($MILLION)
TABLE 55.CHINA INTERBODY FUSION CAGES, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 56.CHINA INTERBODY FUSION CAGES, BY SURGERY, 2020-2030 ($MILLION)
TABLE 57.CHINA INTERBODY FUSION CAGES, BY END USER, 2020-2030 ($MILLION)
TABLE 58.AUSTRALIA INTERBODY FUSION CAGES, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 59.AUSTRALIA INTERBODY FUSION CAGES, BY SURGERY, 2020-2030 ($MILLION)
TABLE 60.AUSTRALIA INTERBODY FUSION CAGES, BY END USER, 2020-2030 ($MILLION)
TABLE 61.INDIA INTERBODY FUSION CAGES, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 62.INDIA INTERBODY FUSION CAGES, BY SURGERY, 2020-2030 ($MILLION)
TABLE 63.INDIA INTERBODY FUSION CAGES, BY END USER, 2020-2030 ($MILLION)
TABLE 64.SOUTH KOREA INTERBODY FUSION CAGES, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 65.SOUTH KOREA INTERBODY FUSION CAGES, BY SURGERY, 2020-2030 ($MILLION)
TABLE 66.SOUTH KOREA INTERBODY FUSION CAGES, BY END USER, 2020-2030 ($MILLION)
TABLE 67.REST OF ASIA PACIFIC INTERBODY FUSION CAGES, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 68.REST OF ASIA PACIFIC INTERBODY FUSION CAGES, BY SURGERY, 2020-2030 ($MILLION)
TABLE 69.REST OF ASIA PACIFIC INTERBODY FUSION CAGES, BY END USER, 2020-2030 ($MILLION)
TABLE 70.LAMEA INTERBODY FUSION CAGES, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 71.LAMEA INTERBODY FUSION CAGES, BY SURGERY, 2020-2030 ($MILLION)
TABLE 72.LAMEA INTERBODY FUSION CAGES, BY END USER, 2020-2030 ($MILLION)
TABLE 73.BRAZIL INTERBODY FUSION CAGES, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 74.BRAZIL INTERBODY FUSION CAGES, BY SURGERY, 2020-2030 ($MILLION)
TABLE 75.BRAZIL INTERBODY FUSION CAGES, BY END USER, 2020-2030 ($MILLION)
TABLE 76.SOUTH AFRICA, INTERBODY FUSION CAGES, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 77.SOUTH AFRICA, INTERBODY FUSION CAGES, BY SURGERY, 2020-2030 ($MILLION)
TABLE 78.SOUTH AFRICA, INTERBODY FUSION CAGES, BY END USER, 2020-2030 ($MILLION)
TABLE 79.SAUDI ARABIA INTERBODY FUSION CAGES, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 80.SAUDI ARABIA INTERBODY FUSION CAGES, BY SURGERY, 2020-2030 ($MILLION)
TABLE 81.SAUDI ARABIA INTERBODY FUSION CAGES, BY END USER, 2020-2030 ($MILLION)
TABLE 82.REST OF LAMEA INTERBODY FUSION CAGES, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 83.REST OF LAMEA INTERBODY FUSION CAGES, BY SURGERY, 2020-2030 ($MILLION)
TABLE 84.REST OF LAMEA INTERBODY FUSION CAGES, BY END USER, 2020-2030 ($MILLION)
TABLE 85.ATOM MEDICAL CORPORATION: KEY EXECUTIVES
TABLE 86.ATOM MEDICAL CORPORATION: COMPANY SNAPSHOT
TABLE 87.ATOM MEDICAL CORPORATION: OPERATING SEGMENTS
TABLE 88.ATOM MEDICAL CORPORATION: PRODUCT PORTFOLIO
TABLE 89.ATOM MEDICAL CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 90.AVI HEALTHCARE PVT. LTD: KEY EXECUTIVES
TABLE 91.AVI HEALTHCARE PVT. LTD: COMPANY SNAPSHOT
TABLE 92.AVI HEALTHCARE PVT. LTD: OPERATING SEGMENTS
TABLE 93.AVI HEALTHCARE PVT. LTD: PRODUCT PORTFOLIO
TABLE 94.AVI HEALTHCARE PVT. LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 95.EQUALIZE HEATH, INC: KEY EXECUTIVES
TABLE 96.EQUALIZE HEATH, INC: COMPANY SNAPSHOT
TABLE 97.EQUALIZE HEATH, INC: OPERATING SEGMENTS
TABLE 98.EQUALIZE HEATH, INC: PRODUCT PORTFOLIO
TABLE 99.EQUALIZE HEATH, INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 100.GE HEALTHCARE: KEY EXECUTIVES
TABLE 101.GE HEALTHCARE: COMPANY SNAPSHOT
TABLE 102.GE HEALTHCARE: OPERATING SEGMENTS
TABLE 103.GE HEALTHCARE: PRODUCT PORTFOLIO
TABLE 104.GE HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 105.IBIS MEDICAL EQUIPMENT AND SYSTEMS PVT. LTD: KEY EXECUTIVES
TABLE 106.IBIS MEDICAL EQUIPMENT AND SYSTEMS PVT. LTD: COMPANY SNAPSHOT
TABLE 107.IBIS MEDICAL EQUIPMENT AND SYSTEMS PVT. LTD: OPERATING SEGMENTS
TABLE 108.IBIS MEDICAL EQUIPMENT AND SYSTEMS PVT. LTD: PRODUCT PORTFOLIO
TABLE 109.IBIS MEDICAL EQUIPMENT AND SYSTEMS PVT. LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 110.NATUS MEDICAL INCORPORATED: KEY EXECUTIVES
TABLE 111.NATUS MEDICAL INCORPORATED: COMPANY SNAPSHOT
TABLE 112.NATUS MEDICAL INCORPORATED: OPERATING SEGMENTS
TABLE 113.NATUS MEDICAL INCORPORATED: PRODUCT PORTFOLIO
TABLE 114.NATUS MEDICAL INCORPORATED: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 115.NINGBO DAVID MEDICAL DEVICE CO. LTD: KEY EXECUTIVES
TABLE 116.NINGBO DAVID MEDICAL DEVICE CO. LTD: COMPANY SNAPSHOT
TABLE 117.NINGBO DAVID MEDICAL DEVICE CO. LTD: OPERATING SEGMENTS
TABLE 118.NINGBO DAVID MEDICAL DEVICE CO. LTD: PRODUCT PORTFOLIO
TABLE 119.NINGBO DAVID MEDICAL DEVICE CO. LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 120.NOVOS MEDICAL DEVICES SAN. TIC. IMP. AND IHR. LTD. STI.: KEY EXECUTIVES
TABLE 121.NOVOS MEDICAL DEVICES SAN. TIC. IMP. AND IHR. LTD. STI.: COMPANY SNAPSHOT
TABLE 122.NOVOS MEDICAL DEVICES SAN. TIC. IMP. AND IHR. LTD. STI.: OPERATING SEGMENTS
TABLE 123.NOVOS MEDICAL DEVICES SAN. TIC. IMP. AND IHR. LTD. STI.: PRODUCT PORTFOLIO
TABLE 124.NOVOS MEDICAL DEVICES SAN. TIC. IMP. AND IHR. LTD. STI.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 125.WEYER GMBH: KEY EXECUTIVES
TABLE 126.WEYER GMBH: COMPANY SNAPSHOT
TABLE 127.WEYER GMBH: OPERATING SEGMENTS
TABLE 128.WEYER GMBH: PRODUCT PORTFOLIO
TABLE 129.WEYER GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 130.ZHENGZHOU DISON INSTRUMENT AND METER CO. LTD: KEY EXECUTIVES
TABLE 131.ZHENGZHOU DISON INSTRUMENT AND METER CO. LTD: COMPANY SNAPSHOT
TABLE 132.ZHENGZHOU DISON INSTRUMENT AND METER CO. LTD: OPERATING SEGMENTS
TABLE 133.ZHENGZHOU DISON INSTRUMENT AND METER CO. LTD: PRODUCT PORTFOLIO
TABLE 134.ZHENGZHOU DISON INSTRUMENT AND METER CO. LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 1.GLOBAL INTERBODY FUSION CAGES MARKET SEGMENTATION
FIGURE 2.GLOBAL INTERBODY FUSION CAGES MARKET
FIGURE 3.SEGMENTATION INTERBODY FUSION CAGES MARKET
FIGURE 4.TOP INVESTMENT POCKET IN INTERBODY FUSION CAGES MARKET
FIGURE 5.TOP WINNING STRATEGIES, 2019-2021*
FIGURE 6.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2019-2021(%)
FIGURE 7.TOP WINNING STRATEGIES, BY COMPANY, 2019-2021*
FIGURE 8.MODERATE BARGAINING POWER OF BUYERS
FIGURE 9.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 10.MODERATE THREAT OF NEW ENTRANTS
FIGURE 11.LOW THREAT OF SUBSTITUTION
FIGURE 12.HIGH COMPETITIVE RIVALRY
FIGURE 13.TOP PLAYER POSITIONING, 2020
FIGURE 14.MARKET SHARE ANALYSIS, 2020
FIGURE 15.RESTRAINTS AND DRIVERS: INTERBODY FUSION CAGES MARKET
FIGURE 16.INTERBODY FUSION CAGES MARKET SEGMENTATION, BY PRODUCT
FIGURE 17.INTERBODY FUSION CAGES MARKET FOR LUMBAR, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 18.INTERBODY FUSION CAGES MARKET FOR CERVICAL, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 19.INTERBODY FUSION CAGES MARKET FOR THORACO LUMBAR, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 20.INTERBODY FUSION CAGES MARKET FOR THORACIC, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 21.INTERBODY FUSION CAGES MARKET SEGMENTATION, BY SURGERY
FIGURE 22.INTERBODY FUSION CAGES MARKET FOR ANTERIOR, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 23.INTERBODY FUSION CAGES MARKET FOR TRANSFORAMINAL, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 24.INTERBODY FUSION CAGES MARKET FOR POSTERIOR, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 25.INTERBODY FUSION CAGES MARKET FOR LATERAL, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 26.INTERBODY FUSION CAGES MARKET SEGMENTATION, BY END USER
FIGURE 27.INTERBODY FUSION CAGES MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 28.INTERBODY FUSION CAGES MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 29.INTERBODY FUSION CAGES MARKET FOR OTHERS, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 30.ATOM MEDICAL CORPORATION: NET SALES, 2018-2020 ($MILLION)
FIGURE 31.ATOM MEDICAL CORPORATION: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 32.ATOM MEDICAL CORPORATION: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 33.AVI HEALTHCARE PVT. LTD: NET SALES, 2018-2020 ($MILLION)
FIGURE 34.AVI HEALTHCARE PVT. LTD: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 35.AVI HEALTHCARE PVT. LTD: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 36.EQUALIZE HEATH, INC: NET SALES, 2018-2020 ($MILLION)
FIGURE 37.EQUALIZE HEATH, INC: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 38.EQUALIZE HEATH, INC: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 39.GE HEALTHCARE: NET SALES, 2018-2020 ($MILLION)
FIGURE 40.GE HEALTHCARE: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 41.GE HEALTHCARE: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 42.IBIS MEDICAL EQUIPMENT AND SYSTEMS PVT. LTD: NET SALES, 2018-2020 ($MILLION)
FIGURE 43.IBIS MEDICAL EQUIPMENT AND SYSTEMS PVT. LTD: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 44.IBIS MEDICAL EQUIPMENT AND SYSTEMS PVT. LTD: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 45.NATUS MEDICAL INCORPORATED: NET SALES, 2018-2020 ($MILLION)
FIGURE 46.NATUS MEDICAL INCORPORATED: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 47.NATUS MEDICAL INCORPORATED: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 48.NINGBO DAVID MEDICAL DEVICE CO. LTD: NET SALES, 2018-2020 ($MILLION)
FIGURE 49.NINGBO DAVID MEDICAL DEVICE CO. LTD: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 50.NINGBO DAVID MEDICAL DEVICE CO. LTD: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 51.NOVOS MEDICAL DEVICES SAN. TIC. IMP. AND IHR. LTD. STI.: NET SALES, 2018-2020 ($MILLION)
FIGURE 52.NOVOS MEDICAL DEVICES SAN. TIC. IMP. AND IHR. LTD. STI.: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 53.NOVOS MEDICAL DEVICES SAN. TIC. IMP. AND IHR. LTD. STI.: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 54.WEYER GMBH: NET SALES, 2018-2020 ($MILLION)
FIGURE 55.WEYER GMBH: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 56.WEYER GMBH: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 57.ZHENGZHOU DISON INSTRUMENT AND METER CO. LTD: NET SALES, 2018-2020 ($MILLION)
FIGURE 58.ZHENGZHOU DISON INSTRUMENT AND METER CO. LTD: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 59.ZHENGZHOU DISON INSTRUMENT AND METER CO. LTD: REVENUE SHARE, BY REGION, 2020 (%)
According to CXOs, the interbody fusion cage market is projected to witness an increase in forecast period, owing to rapid rise in geriatric population and increase in incidence of spinal injuries. Novel interbody fusion cages have emerged as promising medical devices that provide mechanical support as well as offer stabilization to the spine. Moreover, the launch of innovative interbody fusion cages and rise in demand for minimally invasive surgeries are projected to further aid in supplementing the market growth. However, the cost associated with spinal fusion devices and surgeries are higher that impedes the growth of interbody fusion cage market. However, increased adoption of minimally invasive surgeries is expected to further create lucrative opportunities in the market.
Moreover, Asia-Pacific is anticipated to grow at a fast pace, owing to its high population base and significant increase in spinal injuries. In addition, surge in medical tourism, growth in disposable income, and rise in awareness among patients toward advanced interbody fusion devices boost the market growth in this region. Moreover, the medical device companies such as Titan Spine, Inc., and K2M have penetrated Asia-Pacific and launched several interbody fusion devices.
A. The total market value of Interbody Fusion Cages Market is $3,012.47 Million in 2030
A. The forecast period in the report is from 2021 to 2030
A. The market value of Interbody Fusion Cage in 2020 was 1,901.67 million in 2020
A. The base year for the report is 2020
A. Yes, Interbody Fusion Cage Market companies are profiled in the report
A. The top companies that hold the market share in Interbody Fusion Cage Market are Aurora Spine, Inc., B. Braun Melsungen AG, Benvenue Medical Inc., Prodorth, Ulrich Medicals
A. No, there is no value chain analysis provided in the Interbody Fusion Cage Market report
A. The key trends in the Interbody Fusion Cage Market are increase in prevalence of spinal cord disorders along with rise in elderly population are the key factors driving the market growth.t
Start reading instantly.
This Report and over 66,905+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Contact Details
Need to talk to an expert? Book your free consultation and let our research experts help you with your needs/problems.
Global Report 
Regional Report
Country Report
Related Report